IL6 and obesity disorder: Our data indicate that negative control of IL-6 signaling is increased in myocytes in obesity, whereas a dysfunctional IL-6 signaling is established further downstream of IL-6Rα in DM myocytes, resulting in a failure in activating gene expression and metabolic rate.